Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning
Drug Design, Development and Therapy · 2025-05 · Volume 19 · 3631-3643
DOI: 10.2147/dddt.s515535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-05. Verfasst von Jin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, People's Repub…. Hauptthemen laut MEDLINE: Methotrexate, Osteosarcoma, Machine Learning, Bone Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, People's Republic of China.
- Department of Pharmacy, Qujing Medical College, Qujing, Yunnan, 655000, People's Republic of China.
Zitieren
APA
Zhao, J., Dai, S., He, J., Liu, N., Zhang, B., & Li, S. (2025). Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning. Drug Design, Development and Therapy, Volume 19, 3631-3643. https://doi.org/10.2147/dddt.s515535
Vancouver
Zhao J, Dai S, He J, Liu N, Zhang B, Li S. Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning. Drug Design, Development and Therapy. 2025;Volume 19:3631-3643. doi:10.2147/dddt.s515535
BibTeX
@article{Zhao2025,
author = {Zhao, Jin and Dai, Shuqi and He, Jiali and Liu, Na and Zhang, Baowanze and Li, Su},
title = {Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {3631--3643},
doi = {10.2147/dddt.s515535}
}
EUVIMED